Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?

Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?

Idiopathic pulmonary fibrosis (IPF) identifies a specific entity characterized by chronic, progressive fibrosing interstitial pneumonia of unknown cause, still lacking effective therapies. Growing evidence suggests that the biologic processes occurring in IPF recall those which orchestrate cancer on...

Full description

Bibliographic Details
Main Authors:	Sara Lettieri, Tiberio Oggionni, Andrea Lancia, Chandra Bortolotto, Giulia Maria Stella
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	International Journal of Molecular Sciences
Subjects:	fibrosis cancer immune system microenvironment genetics targeted therapy
Online Access:	https://www.mdpi.com/1422-0067/22/6/2882

Similar Items

Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis
by: Xinyu Li, et al.
Published: (2021-06-01)

New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis
by: Zhao Ni Wang, et al.
Published: (2020-09-01)

Lung Transplantation in Idiopathic Pulmonary Fibrosis
by: Rosalía Laporta Hernandez, et al.
Published: (2018-08-01)

The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
by: Akira Saito, et al.
Published: (2018-11-01)

Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis
by: Giulia M. Stella, et al.
Published: (2014-10-01)

A case of lung adenocarcinoma with idiopathic pulmonary fibrosis
by: Arnab Saha, et al.
Published: (2014-01-01)

Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment
by: Xiaoqing Sang, et al.
Published: (2021-02-01)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
by: Elisabetta Balestro, et al.
Published: (2019-10-01)

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses
by: Alice Guyard, et al.
Published: (2017-06-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)

Research Progress in the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Cancer
by: Chunhui LIU, et al.
Published: (2020-08-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling
by: Dong Leng, et al.
Published: (2020-10-01)

Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis
by: Sabah Ahmed, et al.
Published: (2016-01-01)

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
by: Liteng Lin, et al.
Published: (2020-04-01)

Autophagy, Apoptosis, the Unfolded Protein Response, and Lung Function in Idiopathic Pulmonary Fibrosis
by: Pawan Sharma, et al.
Published: (2021-06-01)

Erythropoietin: role in idiopathic pulmonary fibrosis revisited
by: Contributors A.O Abdel-Aziz, et al.
Published: (2020-01-01)

Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis
by: Hasancan Bilgili, et al.
Published: (2019-08-01)

Lung transplantation for idiopathic pulmonary fibrosis: A narrative review
by: Nazia Mehfooz, et al.
Published: (2021-01-01)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
by: Esteban Cano-Jiménez, et al.
Published: (2018-08-01)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
by: Xunliang Tong, et al.
Published: (2019-05-01)

Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis
by: Milica Vukmirovic, et al.
Published: (2018-04-01)

Activated MC<sub>TC </sub>mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
by: Löfdahl Claes-Göran, et al.
Published: (2011-10-01)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01)

Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report
by: Ibrahim Ismail, et al.
Published: (2017-08-01)

MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics
by: Huimin Li, et al.
Published: (2016-10-01)

Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function
by: Xiyue Zhang, et al.
Published: (2021-04-01)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
by: Sung Woo Moon, et al.
Published: (2019-10-01)

The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
by: Paolo Spagnolo, et al.
Published: (2019-11-01)

Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies
by: Serena Diazzi, et al.
Published: (2020-05-01)

The hematopoietic stroma
by: N.B. Nardi, et al.
Published: (1999-05-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
by: Manolescu D, et al.
Published: (2018-03-01)

Cell Therapy in Idiopathic Pulmonary Fibrosis†
by: Anna Serrano-Mollar
Published: (2018-08-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Differential diagnosis of idiopathic pulmonary fibrosis
by: E. I. Shmelev, et al.
Published: (2020-03-01)

NERVES, COUGH, AND IDIOPATHIC PULMONARY FIBROSIS
by: Nicholas Kim Harrison, et al.
Published: (2015-05-01)

Idiopathic pulmonary fibrosis with bronchogenic carcinoma
by: Nair Girija, et al.
Published: (2009-01-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
by: Tanyalak Parimon, et al.
Published: (2020-03-01)